FDA/CDC

CDC finds that efforts to reduce new HIV infections have stalled


 

FROM THE CDC

Proposed initiative focuses on areas of greatest need

The proposed Ending the HIV Epidemic initiative, if it is funded, will target the locations of greatest need throughout the country. Its initial focus will be on 50 areas that account for more than half of new HIV diagnoses, including 48 counties; San Juan, Puerto Rico; and Washington, D.C. It also will direct resources to seven states with high rates of infection in rural areas. In a second phase, the initiative will expand nationwide, provided that additional resources are made available.

The proposed initiative relies on four science-based strategies. First, it will aim to diagnose all Americans with HIV (at least 95% of HIV infections) as early as possible. Second, the initiative will enable people with HIV to receive treatment rapidly and effectively. The CDC’s target is to achieve viral suppression in at least 95% of people with diagnosed HIV. Third, the initiative will use proven interventions such as PrEP and syringe services programs to prevent new HIV transmissions. One related goal is for at least 50% of people who could benefit from PrEP to receive a prescription. Finally, the initiative is intended to respond quickly to potential HIV outbreaks and provide prevention and treatment to those who need them.

The U.S. Department of Health & Human Services already has taken steps to enable the initiative to be implemented quickly if it is funded in 2020. The department has provided funding to Baltimore City, Md.; DeKalb County, Ga.; and East Baton Rouge Parish, La. to begin pursuing parts of the initiative. These communities are encouraged to share the lessons of their experiences with other communities. HHS also has supported local efforts to develop plans under the initiative in all priority geographic areas. These plans draw upon recommendations from the community, HIV-planning bodies, and health care providers.

“Ending the HIV epidemic would be one of the greatest public health triumphs in our nation’s history,” said Dr. McCray.

SOURCES: Centers for Disease Control and Prevention. CDC Vital Signs. 2019 Dec 3. and Harris NS et al. MMWR Morb Mortal Wkly Rep. 2019 Dec 3.

Pages

Recommended Reading

Stem cells gene edited to be HIV resistant treat ALL, but not HIV
MDedge Infectious Disease
New engineered HIV-1 vaccine candidate shows improved immunogenicity in early trial
MDedge Infectious Disease
CAR T-cell therapy found safe, effective for HIV-associated lymphoma
MDedge Infectious Disease
FDA approves Descovy as HIV PrEP for men and transgender women who have sex with men
MDedge Infectious Disease
California bans “Pay for Delay,” promotes black maternal health, PrEP access
MDedge Infectious Disease
NIH seeks gene-based cures for HIV, sickle cell disease
MDedge Infectious Disease
ART traces in donor samples show risk to blood supply
MDedge Infectious Disease
HCV testing/awareness successful as part of HIV integrated care
MDedge Infectious Disease
Free HIV self-tests for at-risk groups can increase awareness, testing frequency
MDedge Infectious Disease
ART treatment at birth found to benefit neonates with HIV
MDedge Infectious Disease